C-Mer Eye Care Holdings

Business Overview

DESCRIPTION

We are one of the leading ophthalmic service providers in Hong Kong and Guangdong Province established under the brand of “C-MER Dennis Lam (希瑪林順潮)”. Headquartered in Hong Kong, we became the first foreign investor to wholly own an eye hospital in the PRC. Our Shenzhen C-MER Dennis Lam Eye Hospital (深圳希瑪林順潮眼科醫院), established in March 2013, is the first and as of the Latest Practicable Date, the only Hong Kong privately-owned hospital established under CEPA according to the Frost & Sullivan Report. Leveraging our first mover advantage and our experience in providing ophthalmic services of international standard in Hong Kong treating a wide range of eye problems from common to rare and complex conditions, we believe we have built one of the leading ophthalmic practices in Shenzhen. Our eye hospital operated by Shenzhen C-MER Hospital ranked third amongst 113 public and private hospitals in Shenzhen in 2016 (overall) and ranked second in the first quarter of 2017 in the quarterly surveys of “Patient Satisfaction” (病人滿意度) conducted by the Shenzhen Health Commission.

Our eye hospital in Beijing has commenced business operations since January 2018. Our fifth satellite clinic in Hong Kong has commenced business operations since March 2018 and our first satellite clinic in Baoan District, Shenzhen has commenced business operations since November 2018.

We have been actively seeking opportunities for expansion in the PRC with demand for high quality ophthalmic services. Other than Beijing, Shenzhen and Hong Kong, we are going to expand the service network in Kunming and Shanghai by acquisition of eye hospitals, and Huizhou by set up of a new eye hospital in 2019.

We are an ophthalmic service provider in Hong Kong and the PRC. Our ophthalmologists/physicians are specialised in the fields of cataract, glaucoma, strabismus and refractive surgeries and external eye diseases.

INVESTOR TYPE
Company
MODEL PREFERENCE
B2B
SERIES PREFERENCE
Series B
OFFERING PREFERENCE
Hardware, Software
AI TYPE PREFERENCE
Computer Vision
SECTORS
Healthcare Non-invasive Ophthalmology

Active Investment Portfolio

Startup

Operating Status

Offering Type

Business Model

Total Funding

AI Employees

Belkin Laser
Active
Hardware, Software
B2B
$25.3 M
2

Exited Investment Portfolio

Startup

Operating Status

Offering Type

Business Model

Total Funding

AI Employees

Investment Rounds History

Startup

Date Announced

Amount Raised

Funding Round

July 2020
$12.25 million
Series B